论文部分内容阅读
目前,对急性慢性肝炎的治疗西医以保肝药,营养药和休息为主。国内外文献报导,完全治愈率只占10.2％。近年来虽经采用免疫抑制疗法;抗纤维化则剂一青雷素胺,氨基脯氨酸,山黧豆素,激素强的松等疗法取得了一定的疗效。但疗效尚不稳定并有副作用。为此我们多年来一直坚持中西医结合的方法探索新的药物。通过动物实验初步证明:温郁金1号注射液
At present, Western medicine for the treatment of acute chronic hepatitis is mainly based on hepatoprotective drugs, nutritional drugs and rest. Domestic and foreign literature reported that the complete cure rate only accounted for 10.2%. Although immunosuppressive therapy has been used in recent years, antifibrotic agents such as blendin, aminoproline, hadarin, and prednisone have achieved certain therapeutic effects. However, the efficacy is still unstable and has side effects. For this reason, we have been adhering to the methods of combining Chinese and Western medicines to explore new drugs for many years. Preliminary proof of animal experiments: Wen Yu Jin 1 injection